Alembic Pharmaceuticals announces US FDA final approval for formoterol fumarate inhalation solution Read more
European Commission approves Roche’s Gavreto to treat adults with RET fusion-positive advanced non-small cell lung cancer Read more
Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from US FDA Read more
FDA approves Verzenio as the first and only CDK4/6 inhibitor for certain people with HR+HER2- high-risk early breast cancer Read more
US FDA grants breakthrough therapy designation to Roche’s anti-amyloid beta antibody gantenerumab Read more